Combination fibrinolytic therapy in the treatment of chronic septic pleuropneumonia in a Thoroughbred gelding

Aust Vet J. 2012 Sep;90(9):358-62. doi: 10.1111/j.1751-0813.2012.00962.x. Epub 2012 Jul 27.

Abstract

This report documents the treatment of a case of chronic pleuropneumonia in a 3-year-old Thoroughbred gelding. A recombinant tissue plasminogen activator (tenecteplase) and a recombinant deoxyribonucleic acidase (alphadornase) were infused into the pleural cavity as adjunctive therapy in the early stages of treatment. Instillation of fibrinolytic drugs was associated with a subjective reduction in the amount of fibrin deposition and decreased fluid accumulation within the pleural cavities. Fibrinolytic therapy may be a useful adjunctive therapy in selected cases of intrapleural disease in horses.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Fibrinolytic Agents / therapeutic use*
  • Horse Diseases / drug therapy*
  • Horses
  • Male
  • Pleural Effusion / drug therapy
  • Pleural Effusion / veterinary
  • Pleuropneumonia / drug therapy
  • Pleuropneumonia / veterinary*
  • Salmonella Infections, Animal / drug therapy
  • Streptococcal Infections / drug therapy
  • Streptococcal Infections / veterinary
  • Streptococcus equi / isolation & purification
  • Thrombolytic Therapy / veterinary*
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Fibrinolytic Agents
  • Tissue Plasminogen Activator